Prevention and management of infectious and tropical diseases in kidney transplant recipients residing in European outermost and overseas territories.
immunosuppression
kidney transplantation
overseas territories
tropical diseases
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
13 Oct 2024
13 Oct 2024
Historique:
revised:
11
09
2024
received:
04
08
2024
accepted:
18
09
2024
medline:
14
10
2024
pubmed:
14
10
2024
entrez:
14
10
2024
Statut:
aheadofprint
Résumé
The European Union encompasses 30 outermost and overseas countries and territories (OCTs). Despite a recent increasing activity of renal transplantation in these territories, many patients still undergo transplantation in continental Europe, with follow-up care coordinated between health professionals from both their transplant center and their home region. Each territory has its unique infectious epidemiology which must be known to ensure appropriate care for kidney transplant recipients (KTRs). This paper proposes a pragmatic approach to optimize pre-transplant check-up and to provide an overview of the specific epidemiological features of each region. It offers practical algorithms to help practitioners in managing infected KTR living in these territories. This work advocates for increased collaborative research among European OCTs.
Sections du résumé
BACKGROUND
BACKGROUND
The European Union encompasses 30 outermost and overseas countries and territories (OCTs). Despite a recent increasing activity of renal transplantation in these territories, many patients still undergo transplantation in continental Europe, with follow-up care coordinated between health professionals from both their transplant center and their home region. Each territory has its unique infectious epidemiology which must be known to ensure appropriate care for kidney transplant recipients (KTRs).
AIMS
OBJECTIVE
This paper proposes a pragmatic approach to optimize pre-transplant check-up and to provide an overview of the specific epidemiological features of each region. It offers practical algorithms to help practitioners in managing infected KTR living in these territories. This work advocates for increased collaborative research among European OCTs.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14386Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Jones J, Gastellu‐Etchegorry M, Stenz FK, et al. Epidemiology, surveillance and control of infectious diseases in the European overseas countries and territories, 2011. Euro Surveill. 2011;16(29):19923.
Rapport de l'Agence de la Biomédecine—Rein. 2021. https://rams.agence‐biomedecine.fr/sites/default/files/pdf/2022‐08/ABM_PG_Organes_Rein2021.pdf
Rapport de l'Agence de la Biomédecine—Rein. 2019. https://www.agence‐biomedecine.fr/IMG/pdf/rapport_rein_2019_2021‐10‐14.pdf
Ajubi N, Roose AC, Engels R, et al. Kidney transplant program facilitated by airlift between the Netherlands Antilles and the Netherlands; 1998‒2001. Ned Tijdschr Geneeskd. 2003;147(44):2174‐2178.
Minnee RC, Lardy N, Ajubi N, et al. Ten‐yr results of the trans‐Atlantic kidney transplant airlift between the Dutch Caribbean and the Netherlands: trans‐Atlantic transplant program. Clin Transplant. 2011;25(2):302‐307.
Bello AK, McIsaac M, Okpechi IG, et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean. Kidney Int Suppl. 2021;11(2):e66‐e76.
Cachera L, Adenis A, Dueymes JM, et al. What is the part of tropical diseases among infectious complications in renal transplant recipients in the Amazon? A 12‐year multicenter retrospective analysis in French Guiana. Transplant Proc. 2021;53(7):2242‐2251.
Clemente WT, Pierrotti LC, Abdala E, et al. Recommendations for management of endemic diseases and travel medicine in solid‐organ transplant recipients and donors: Latin America. Transplantation. 2018;102(2):193‐208.
Epelboin L, Chroboczek T, Mosnier E, et al. L'infectiologie en Guyane: le dernier bastion de la médecine tropicale française. La Lettre de l'Infectiologue. 2016.
Green M, Covington S, Taranto S, et al. Donor‐derived transmission events in 2013: a report of the organ procurement transplant network ad hoc disease transmission advisory committee. Transplantation. 2015;99(2):282‐287.
Böhler K, Rahmel A, Barreiros AP. Vigilance data in organ donation and solid organ transplantation in Germany: six years of experience 2016‒2022. Transpl Int. 2023;36:11610.
Ison MG, Hager J, Blumberg E, et al. Donor‐derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant. 2009;9(8):1929‐1935.
Ison MG, Grossi P. Donor‐derived infections in solid organ transplantation. Am J Transplant. 2013;13:22‐30.
White SL, Rawlinson W, Boan P, et al. Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission. Transplant Direct. 2019;5(1):e416.
Malinis M, Boucher HW, the AST Infectious Diseases Community of Practice. Screening of donor and candidate prior to solid organ transplantation—guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13548.
European Centre for Disease Prevention and Control, World Health Organization, Regional Office for Europe. Tuberculosis Surveillance and Monitoring in Europe 2023: 2021 Data. LU: Publications Office; 2023. https://data.europa.eu/doi/10.2900/637206
Tuberculose en France: les chiffres. 2021. https://www.santepubliquefrance.fr/les‐actualites/2023/tuberculose‐en‐france‐les‐chiffres‐2021
Scemla A, Manda V. Épidémiologie des infections en transplantation rénale [Infectious complications after kidney transplantation]. Nephrol Ther. 2019;15(suppl 1):S37‐S42.
Lopez de Castilla D, Schluger NW. Tuberculosis following solid organ transplantation. Transpl Infect Dis. 2010;12(2):106‐112.
Fishman JA. Infection in renal transplant recipients. Semin Nephrol. 2007;27(4):445‐461.
Batista MV, Pierrotti LC, Abdala E, et al. Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health. 2011;16(9):1134‐1142.
Canet E, Dantal J, Blancho G, et al. Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years, Nephrol Dial Transplant. 2011;26(11):3773‐3778.
Subramanian AK, Theodoropoulos NM, Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant. 2019;33(9):e13513.
Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):111‐115.
Sterling TR, Njie G, Zenner D, et al. Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020;69. https://www.cdc.gov/mmwr/volumes/69/rr/rr6901a1.htm
Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid‐organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998;27(5):1266‐1277.
European Committee on Organ Transplantation. Guide to the Quality and Safety of Organs For Transplantation. 8th ed. 2022. https://freepub.edqm.eu/publications/PUBSD‐88/detail
Morris MI, Daly JS, Blumberg E, et al. Diagnosis and management of tuberculosis in transplant donors: a donor‐derived infections consensus conference report. Am J Transplant. 2012;12(9):2288‐2300.
Kazanji M, Gessain A. Human T‐cell lymphotropic virus types I and II (HTLV‐I/II) in French Guiana: clinical and molecular epidemiology. Cad Saude Publica. 2003;19(5):1227‐1240.
Abdelmoumen K, Alsibai KD, Rabier S, et al. Adult T‐cell leukemia and lymphoma in French Guiana: a retrospective analysis with real‐life data from 2009 to 2019. Lancet Reg Health Am. 2023;21:100492.
Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV‐I infection acquired by transfusion during cardiac transplantation. N Engl J Med. 1990;322(6):383‐388.
Kaul DR, Taranto S, Alexander C, et al. Donor screening for human T‐cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity. Am J Transplant. 2010;10(2):207‐213.
de Mendoza C, Roc L, Benito R, et al. HTLV‐1 infection in solid organ transplant donors and recipients in Spain. BMC Infect Dis. 2019;19(1):706.
Montesdeoca Andrade MJ, Correa Diaz EP, Buestán ME. HTLV‐1‐associated myelopathy in a solid organ transplant recipient. BMJ Case Rep. 2016;2016:bcr2016215243.
Yamauchi J, Yamano Y, Yuzawa K. Risk of human T‐cell leukemia virus type 1 infection in kidney transplantation. N Engl J Med. 2019;380(3):296‐298.
Kaul DR, Sharma TS, the AST ID Community of Practice. Human T‐cell lymphotrophic virus in solid‐organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13575.
Flamand C, Fritzell C, Prince C, et al. Epidemiological assessment of the severity of dengue epidemics in French Guiana. PLoS One. 2017;12(2):e0172267.
L'Azou M, Taurel AF, Flamand C, et al. Recent epidemiological trends of dengue in the French territories of the Americas (2000‒2012): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11):e3235.
Requião‐Moura LR, Daher EDF, Moreira Albino CR, et al. Tropical infections in the context of kidney transplantation in Latin America. Am J Trop Med Hyg. 2021;105(3):564‐572.
Girão ES, Rodrigues Dos Santos BG, do Amaral ES, et al. Chikungunya infection in solid organ transplant recipients. Transplant Proc. 2017;49(9):2076‐2081.
Azevedo LS, Carvalho DBM, Matuck T, et al. Dengue in renal transplant patients: a retrospective analysis. Transplantation. 2007;84(6):792.
Fernandes PFCBC, Siqueira RA, Girão ES, et al. Dengue in renal transplant recipients: clinical course and impact on renal function. World J Transplant. 2017;7(1):57‐63.
Shaji Mathew J, Menon VP, Menon VP, et al. Dengue virus transmission from live donor liver graft. Am J Transplant. 2019;19(6):1838‐1846.
Fischer SA, Avery RK. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant. 2009;9(s4):S7‐S18.
Riccardi N, Giacomelli A, Antonello RM, et al. Rabies in Europe: an epidemiological and clinical update. Eur J Intern Med. 2021;88:15‐20.
Meynard JB, Flamand C, Dupuy C, et al. First human rabies case in French Guiana, 2008: epidemiological investigation and control. PLoS Negl Trop Dis. 2012;6(2):e1537.
Zhang J, Lin J, Tian Y, et al. Transmission of rabies through solid organ transplantation: a notable problem in China. BMC Infect Dis. 2018;18(1):273.
Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1(2):92‐100.
Péneau J, Nguyen A, Flores‐Ferrer A, et al. Amazonian triatomine biodiversity and the transmission of chagas disease in French Guiana: in Medio Stat Sanitas. PLoS Negl Trop Dis. 2016;10(2):e0004427.
Pérez‐Molina JA, Molina I. Chagas disease. Lancet. 2018;391(10115):82‐94.
Pierrotti LC, Carvalho NB, Amorin JP, et al. Chagas disease recommendations for solid‐organ transplant recipients and donors. Transplantation. 2018;102(2S):S1‐S7.
Radisic MV, Repetto SA. American trypanosomiasis (Chagas disease) in solid organ transplantation. Transpl Infect Dis. 2020;22(6):e13429.
Pinazo MJ, Miranda B, Rodríguez‐Villar C, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev. 2011;25(3):91‐101.
Costa ACD, Silva Filho JDD, Rocha EA, et al. Trypanosoma cruzi seroprevalence among solid organ donors in Ceará State, Brazil. Rev Soc Bras Med Trop. 2018;51(5):616‐621.
Salvador F, Len O, Molina I, et al. Safety of liver transplantation with chagas disease‐seropositive donors for seronegative recipients: Chagas disease and liver transplantation. Liver Transpl. 2011;17(11):1304‐1308.
Chin‐Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in Transplant Working Group. Am J Transplant. 2011;11(4):672‐680.
Bosch‐Nicolau P, Fernández ML, Sulleiro E, et al. Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double‐blind, phase 2b trial. Lancet Infect Dis. 2024;24(4):386‐394.
De Sousa AS, Vermeij D, Ramos AN, et al. Chagas disease. Lancet. 2024;403(10422):203‐218.
Machado CM, Martins TC, Colturato I, et al. Epidemiology of neglected tropical diseases in transplant recipients: review of the literature and experience of a Brazilian HSCT center. Rev Inst Med Trop Sao Paulo. 2009;51(6):309‐324.
Schär F, Trostdorf U, Giardina F, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7(7):e2288.
Eperon G, Tourret J, Ailioaie O, et al. Severe Strongyloidiasis in solid organ transplant recipients: should we preventively treat the recipient, the donor, or both? Am J Trop Med Hyg. 2018;98(4):941‐944.
French High Council of Public Health. Opinion Regarding the Risk of Contamination with Strongyloides stercoralis Following Transplantation of Human Body Products. 2023. https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=1340
Adeyemo A, Montgomery S, Chancey RJ, et al. Investigation of donor‐derived Strongyloides stercoralis infection in multiple solid organ transplant recipients—California, Michigan, Ohio, 2022. Transplant Infectious Dis. 2023;25(3):e14059.
Nordheim E, Olafsson Storrø M, Natvik AK, et al. Donor‐derived strongyloidiasis after organ transplantation in Norway. Transplant Infectious Dis. 2019;21(1):e13008.
Requena‐Méndez A, Buonfrate D, Gomez‐Junyent J, et al. Evidence‐based guidelines for screening and management of Strongyloidiasis in non‐endemic countries. Am J Trop Med Hyg. 2017;97(3):645–652.
Buonfrate D, Salas‐Coronas J, Muñoz J, et al. Multiple‐dose versus single‐dose ivermectin for Strongyloides stercoralis infection (strong treat 1 to 4): a multicentre, open‐label, phase 3, randomised controlled superiority trial. Lancet Infect Dis. 2019;19(11):1181‐1190.
Tarantola A, Eltges F, Ardillon V, et al. Le paludisme en France: métropole et outre‐mer. Med Mal Infect. 2011;41(6):301‐306.
Rosso F, Agudelo Rojas OL, Suarez Gil CC, et al. Transmission of malaria from donors to solid organ transplant recipients: a case report and literature review. Transpl Infect Dis. 2021;23(4):e13660.
Ison MG, Nalesnik MA. An update on donor‐derived disease transmission in organ transplantation. Am J Transplant. 2011;11(6):1123‐1130.
Martín‐Dávila P, Fortún J, López‐Vélez R, et al. Transmission of tropical and geographically restricted infections during solid‐organ transplantation. Clin Microbiol Rev. 2008;21(1):60‐96.
Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671
Dandrieux JRS, Sacchini F, Harms G, et al. Canine Leishmania infantum infection: an imported case in UK after staying in the Canary Islands. Parasitol Res. 2018;117(1):331‐334.
Pasquier G, Demar M, Lami P, et al. Leishmaniasis epidemiology in endemic areas of metropolitan France and its overseas territories from 1998 to 2020. PLoS Negl Trop Dis. 2022;16(10):e0010745.
Antinori S, Cascio A, Parravicini C, et al. Leishmaniasis among organ transplant recipients. Lancet Infect Dis. 2008;8(3):191‐199.
Cuellar‐Rodriguez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49(5):710‐716.
Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20(1):115‐132.
Gajurel K, Dhakal R, Deresinski S. Histoplasmosis in transplant recipients. Clin Transplant. 2017;31(10):e13087.
Singh N, Huprikar S, Burdette SD, et al. Donor‐derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice. Am J Transplant. 2012;12(9):2414‐2428.
Len O, Los‐Arcos I, Aguado JM, et al. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the selection criteria of donors of solid organs in relation to infectious diseases. Enferm Infecc Microbiol Clin. 2020;38(8):379‐389.
Danziger‐Isakov L, Kumar D, The AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13563.
Croce E, Hatz C, Jonker EF, et al. Safety of live vaccinations on immunosuppressive therapy in patients with immune‐mediated inflammatory diseases, solid organ transplantation or after bone‐marrow transplantation—a systematic review of randomized trials, observational studies and case reports. Vaccine. 2017;35(9):1216‐1226.
Thomas C, Michaud C, Gaillet M, et al. Yellow fever reemergence risk in the Guiana shield: a comprehensive review of cases between 1990 and 2022. Curr Trop Med Rep. 2023;10(3):138‐145.
Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant. 2005;5(1):8‐14.
Buchan CA, Kotton CN, AST Infectious Diseases Community of Practice. Travel medicine, transplant tourism, and the solid organ transplant recipient—guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13529.
Wyplosz B, Burdet C, François H, et al. Persistence of yellow fever vaccine‐induced antibodies after solid organ transplantation. Am J Transplant. 2013;13(9):2458‐2461.
Migueres M, Lhomme S, Izopet J. Hepatitis A: epidemiology, high‐risk groups, prevention and research on antiviral treatment. Viruses. 2021;13(10):1900.
Milligan R, Paul M, Richardson M, et al. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev. 2018;2018(5):CD001261.
Lin FYC, Ho VA, Khiem HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two‐to‐five‐year‐old children. N Engl J Med. 2001;344(17):1263‐1269.
Agrawal A, Ison MG, Danziger‐Isakov L. Long‐term infectious complications of kidney transplantation. Clin J Am Soc Nephrol. 2022;17(2):286‐295.
Gerasymchuk L, Swami A, Carpenter CF, et al. Case of fulminant leptospirosis in a renal transplant patient. Transpl Infect Dis. 2009;11(5):454‐457.
Faucher JF, Chirouze C, Hoen B, et al. Short‐course treatment with ceftriaxone for leptospirosis: a retrospective study in a single center in Eastern France. J Infect Chemother. 2015;21(3):227‐228.
Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3(12):757‐771.
Vieira ML, Gama‐Simões MJ, Collares‐Pereira M. Human leptospirosis in Portugal: a retrospective study of eighteen years. Int J Infect Dis. 2006;10(5):378‐386.
Le Turnier P, Mosnier E, Schaub R, et al. Epidemiology of human leptospirosis in French Guiana (2007‒2014): a retrospective study. Am J Trop Med Hyg. 2018;99(3):590‐596.
Cassadou S, Rosine J, Flamand C, et al. Underestimation of Leptospirosis incidence in the French West Indies. PLoS Negl Trop Dis. 2016;10(4):e0004668.
Massenet D, Yvon JF, Couteaux C, et al. An unprecedented high incidence of Leptospirosis in Futuna, South Pacific, 2004‒2014, evidenced by retrospective analysis of surveillance data. PLoS One. 2015;10(11):e0142063.
Dewart CM, Almeida FA, Koval C, et al. Subclinical Burkholderia pseudomallei infection associated with travel to the British Virgin Islands. Emerg Infect Dis. 2021;27(12):3182‐3184.
Birnie E, Virk HS, Savelkoel J, et al. Global burden of melioidosis in 2015: a systematic review and data synthesis. Lancet Infect Dis. 2019;19(8):892‐902.
Pasquier J, Olive C, Hurtrel G, et al. Melioidosis. Lancet Infect Dis. 2019;19(10):1057.
Muthina RA, Koppara NK, Bethasaida Manuel M, et al. Cerebral abscess and calvarial osteomyelitis caused by Burkholderia pseudomallei in a renal transplant recipient. Transpl Infect Dis. 2021;23(2):e13530.
Sullivan RP, Marshall CS, Anstey NM, et al. 2020 review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift. PLoS Negl Trop Dis. 2020;14(9):e0008659.
Anunnatsiri S, Chaowagul W, Teparrukkul P, et al. A comparison between 12 versus 20 weeks of trimethoprim‒sulfamethoxazole as oral eradication treatment for melioidosis: an open‐label, pragmatic, multicenter, non‐inferiority, randomized controlled trial. Clin Infect Dis. 2021;73(11):e3627‐e3633.
Epelboin L, Chesnais C, Boullé C, et al. Q fever pneumonia in French Guiana: prevalence, risk factors, and prognostic score. Clin Infect Dis. 2012;55(1):67‐74.
Melenotte C, Protopopescu C, Million M, et al. Clinical features and complications of Coxiella burnetii infections from the French National Reference Center for Q fever. JAMA Netw Open. 2018;1(4):e181580.
Epelboin L, Mahamat A, Bonifay T, et al. Q fever as a cause of community‐acquired pneumonia in French Guiana. Am J Trop Med Hyg. 2022;107(2):407‐415.
Godinho I, Nogueira EL, Santos CM, et al. Chronic Q fever in a renal transplant recipient: a case report. Transplant Proc. 2015;47(4):1045‐1047.
Paris DH, Dumler JS. State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus. Curr Opin Infect Dis. 2016;29(5):433‐439.
Parola P, Paddock CD, Socolovschi C, et al. Update on tick‐borne rickettsioses around the world: a geographic approach. Clin Microbiol Rev. 2013;26(4):657‐702.
Grouteau G, Lancelot O, Bertolotti A, et al. Emergence of murine typhus in La Réunion, France, 2012‒2017. Med Mal Infect. 2020;50(1):22‐27.
Robaina‐Bordón JM, Carranza‐Rodríguez C, Hernández‐Cabrera M, et al. Murine typhus in Canary Islands, Spain, 1999‒2015. Emerg Infect Dis. 2021;27(2):570‐573.
Gérardin P, Zemali N, Bactora M, et al. Seroprevalence of typhus group and spotted fever group Rickettsia exposures on Reunion island. BMC Res Notes. 2019;12(1):387.
Balleydier E, Camuset G, Socolovschi C, et al. Murine typhus, Reunion, France, 2011‒2013. Emerg Infect Dis. 2015;21(2):316‐319.
Newton PN, Keolouangkhot V, Lee SJ, et al. A prospective, open‐label, randomized trial of doxycycline versus azithromycin for the treatment of uncomplicated murine typhus. Clin Infect Dis. 2019;68(5):738‐747.
Phatharodom P, Limsrichamrern S, Kaewwinud J, et al. Murine typhus in a liver transplant recipient: report of a first case. Transpl Infect Dis. 2015;17(4):574‐578.
Rosso F, Rodríguez S, Cedano JA, et al. Chikungunya in solid organ transplant recipients, a case series and literature review. Transpl Infect Dis. 2018;20(6):e12978.
Rosso F, Sanz AM, Parra‐Lara LG, et al. Dengue virus infection in solid organ transplant recipients: a case series and literature review. Am J Trop Med Hyg. 2019;101(6):1226‐1231.
Moura‐Neto JA, Braga Silva CA, Moura AF, et al. Emergent arboviruses and renal transplantation: a global challenge. Kidney Int Rep. 2019;4(5):647‐655.
Pinsai S, Kiertiburanakul S, Watcharananan SP, et al. Epidemiology and outcomes of dengue in kidney transplant recipients: a 20‐year retrospective analysis and comparative literature review. Clin Transplant. 2019;33(1):e13458.
Nasim A, Anis S, Baqi S, et al. Clinical presentation and outcome of dengue viral infection in live‐related renal transplant recipients in Karachi, Pakistan. Transpl Infect Dis. 2013;15(5):516‐525.
Weerakkody RM, Patrick JA, Sheriff MHR. Dengue fever in renal transplant patients: a systematic review of literature. BMC Nephrol. 2017;18(1):15.
Nogueira ML, Estofolete CF, Terzian ACB, et al. Zika virus infection and solid organ transplantation: A new challenge. Am J Transplant. 2017;17(3):791‐795.
Mermond S, Guigon A, Berlioz‐Arthaud A. Un cas d'histoplasmose disséminée a Histoplasma capsulatum en Nouvelle‐Calédonie. http://webistem.com/psi2009/output_directory/cd1/Data/articles/000473.pdf
Peters EJG, Kauffmann RH, Blok P. Fever and high lactate dehydrogenase in HIV‐positive patients from the Antilles and Surinam: histoplasmosis? Neth J Med. 2006;64(8):302‐306.
Santé Publqiue France. Situation Épidémiologique du Paludisme en Guyane. Point au 7 juillet 2023. https://www.santepubliquefrance.fr/regions/guyane/documents/bulletin‐regional/2023/situation‐epidemiologique‐du‐paludisme‐en‐guyane.‐point‐au‐7‐juillet‐2023
Santé Publique France. Point sur le Paludisme à Mayotte. 5 juillet 2023. https://www.santepubliquefrance.fr/regions/ocean‐indien/documents/bulletin‐regional/2023/point‐sur‐le‐paludisme‐a‐mayotte.‐5‐juillet‐2023
Elsharif M, Imam M, Elsharif E, et al. Malaria incidence among kidney‐transplanted recipients in an endemic malaria area, Sudan. Saudi J Kidney Dis Transpl. 2012;23(5):1099.
van Griensven J, Carrillo E, López‐Vélez R, et al. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014;20(4):286‐299.
Pace D. Leishmaniasis. J Infect. 2014;69:S10‐S18.
Adenis AA, Valdes A, Cropet C, et al. Burden of HIV‐associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018;18(10):1150‐1159.
Nacher M, Adenis A, Mc Donald S, et al. Disseminated histoplasmosis in HIV‐infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis. 2013;7(11):e2319.
Nacher M, Couppié P, Epelboin L, et al. Disseminated histoplasmosis: fighting a neglected killer of patients with advanced HIV disease in Latin America. PLoS Pathog. 2020;16(5):e1008449.
Vantilcke V, Boukhari R, Jolivet A, et al. Fever in hospitalized HIV‐infected patients in Western French Guiana: first think histoplasmosis. Int J STD AIDS. 2014;25(9):656‐661.
Epelboin L, Dione A, Serris A, et al. Histoplasmosis of the central nervous system: a case series between 1990 and 2019 in French Guiana. Am J Trop Med Hyg. 2021;105(1):125‐129.
Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med. 2002;137(2):105‐109.
Gupta RK. Opportunistic infections in renal allograft recipients. Transplant Proc. 2007;39(3):731‐733.
Guimarães LFA, Halpern M, de Lemos AS, et al. Invasive fungal disease in renal transplant recipients at a Brazilian center: local epidemiology matters. Transplant Proc. 2016;48(7):2306‐2309.